NEP INTERLONG (08329.HK): Controlling Shareholder Receives Regulatory Decision Ordering Rectification, Occupied Funds to Be Returned within Six Months

NewTimeSpace News: On 31 August 2026, Shenzhen Neptunus Interlong Bio-Tech Technique Company Limited (stock code: 08329) issued a voluntary announcement that its controlling shareholder, Shenzhen Neptunus Bioengineering Co., Ltd. (Neptunus Bioengineering), had received a decision from the Shenzhen Bureau of the China Securities Regulatory Commission (CSRC Shenzhen Bureau), pursuant to which the CSRC Shenzhen Bureau decided to impose rectification measures on Neptunus Bioengineering and its controlling shareholder.

According to the announcement, the decision stated that Neptunus Bioengineering should take active measures to recover the occupied funds so as to safeguard the interests of the listed company and minority shareholders, and that its controlling shareholder should earnestly fulfill its primary responsibilities and actively raise funds to repay the occupied funds. Neptunus Bioengineering and its controlling shareholder should draw lessons from the matter, strengthen their study of securities laws and regulations and prevent the recurrence of such non-compliance; all occupied funds should be returned within six months from the receipt of the decision, and a written report should be submitted to the CSRC Shenzhen Bureau upon completion of the rectification.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.